neuraxis.com (NRXS): שווי פעילות לרווח לפני ריבית, מסים ופחת

NeurAxis, Inc. (NRXS) collaborates closely with specialized clinics to implement methods for combating abdominal pain in youth. Due to its status as a leading developer in pediatrics, the brand enjoys the absolute trust of physicians. The price action on GURU.Markets confirms its status as a neurostimulation leader, where product uniqueness ensures a stable cash flow and a margin of 0.00, generating benchmark profits.

Investors are assessing the resilience of NeurAxis, Inc. (NRXS) through the ratio of enterprise value, including net debt, to EBITDA. By analyzing the EV/EBITDA multiple chart for the business, one can understand how ESG compliance costs and the implementation of digital diagnostics impact the company's fundamental value relative to its ability to generate cash flow under high debt leverage.